Dec 22 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS CORP. TO ACQUIRE VIVO CANNABIS INC.
* VIVO CANNABIS INC - UPON COMPLETION OF TRANSACTION,
EXISTING
MEDIPHARM SHAREHOLDERS ARE EXPECTED TO OWN BETWEEN 65% AND 79%
OF COMBINED COMPANY
* VIVO CANNABIS INC - UPON COMPLETION OF TRANSACTION VIVO
SHAREHOLDERS ARE EXPECTED TO OWN BETWEEN 35% AND 21% OF COMBINED
COMPANY
* VIVO CANNABIS INC- TERMINATION FEE OF $1M PAYABLE TO
EITHER
PARTY IN CERTAIN CIRCUMSTANCES
Source text for Eikon: ID:nCNWbWNT6a
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))